Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma? (Q51198337)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 May 2006

Language	Label	Description	Also known as
English	Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma?	scientific article published on 18 May 2006

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710666%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma? (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710666%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

based on heuristic

inferred from title

Josep M. Llovet

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710666%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710666%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710666%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

R Vilana

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710666%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

L Bianchi

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710666%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

M Varela

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710666%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

C Nicolau

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710666%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

M Sánchez

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710666%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

M García

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710666%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

M Sala

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710666%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

C Bru

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710666%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

BCLC Group

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710666%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

language of work or name

0 references

publication date

18 May 2006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710666%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

European Radiology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710666%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710666%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710666%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

2454-2462

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710666%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

https://scigraph.springernature.com/pub.10.1007/s00330-006-0264-8

0 references

Contrast-enhanced subtraction harmonic sonography for evaluating treatment response in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00330-006-0264-8

21 January 2018

Percutaneous ablation therapy guided by contrast-enhanced sonography for patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00330-006-0264-8

21 January 2018

Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-006-0264-8

21 January 2018

Contrast-enhanced sonographic appearance of hepatocellular carcinoma in patients with cirrhosis: comparison with contrast-enhanced helical CT appearance.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-006-0264-8

21 January 2018

Contrast-enhanced sonography with SonoVue: enhancement patterns of benign focal liver lesions and correlation with dynamic gadobenate dimeglumine-enhanced MRI.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-006-0264-8

21 January 2018

Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/16710666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/16710666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma treatment with percutaneous ethanol injection: evaluation with contrast-enhanced color Doppler US

1 reference

https://pubmed.ncbi.nlm.nih.gov/16710666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimating the world cancer burden: Globocan 2000.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16710666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT

1 reference

https://pubmed.ncbi.nlm.nih.gov/16710666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16710666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring RF ablation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16710666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results

1 reference

https://pubmed.ncbi.nlm.nih.gov/16710666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contrast-enhanced gray-scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16710666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16710666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://pubmed.ncbi.nlm.nih.gov/16710666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/16710666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Benign focal liver lesions: spectrum of findings on SonoVue-enhanced pulse-inversion ultrasonography

1 reference

https://pubmed.ncbi.nlm.nih.gov/16710666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16710666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Which continuous US scanning mode is optimal for the detection of vascularity in liver lesions when enhanced with a second generation contrast agent?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16710666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison between color power Doppler ultrasound with echo-enhancer and spiral computed tomography in the evaluation of hepatocellular carcinoma vascularization before and after ablation procedures

1 reference

https://pubmed.ncbi.nlm.nih.gov/16710666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multi-centre clinical study evaluating the efficacy of SonoVue (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/16710666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring of liver metastases after stereotactic radiotherapy using low-MI contrast-enhanced ultrasound?initial results

1 reference

https://pubmed.ncbi.nlm.nih.gov/16710666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound

1 reference

https://pubmed.ncbi.nlm.nih.gov/16710666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Usefulness of contrast-enhanced ultrasonography with a new contrast mode, Agent Detection Imaging, in evaluating therapeutic response in hepatocellular carcinoma treated with radio-frequency ablation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16710666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance

1 reference

https://pubmed.ncbi.nlm.nih.gov/16710666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of focal liver lesions with a new ultrasound contrast agent using continuous low acoustic power imaging: comparison with contrast enhanced spiral CT

1 reference

https://pubmed.ncbi.nlm.nih.gov/16710666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BR1: a new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbles

1 reference

https://pubmed.ncbi.nlm.nih.gov/16710666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of therapeutic response in hepatocellular carcinoma treated with percutaneous radio frequency ablation: comparison of multiphase helical computed tomography and power Doppler ultrasonography with a microbubble contrast agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/16710666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16710666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16710666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power doppler sonography to assess treatment outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/16710666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spiral computed tomography versus ultrasound in the follow-up of cirrhotic patients previously treated for hepatocellular carcinoma: a prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16710666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00330-006-0264-8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710666%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710666%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51198337&oldid=2104863994"